Japan: There is more medicine to come

By James Dowey, Chief Economist & CIO

In a Q&A James Dowey, Chief Economist & CIO, looks at the recent impact of China on Japan and explains why the medicine itself of Abenomics – as distinct from the effects of the medicine – is extremely important for Japanese equities.

Click here to read the full article.

Important Information: investment risks

The value of an investment and any income from it can fall as well as rise and you may not get back the amount originally invested. Forecasts and past performance are not a guide to future performance. These are Neptune’s views and as such this document is deemed to be impartial research. Any forecasts, projections or targets are to provide you with an indication only and should not be relied upon. Investments in emerging markets are higher risk and potentially more volatile than those in established markets. Some information and statistical data herein has been obtained from sources we believe to be reliable but in no way are warranted by us as to their accuracy or completeness. The content of this article is formed from Neptune’s views and we do not undertake to advise you as to any change of our views. Neptune does not give investment advice and only provides information on Neptune products.